The use of GLP-1 receptor agonists has been associated with an increased risk of gallbladder disease in some studies, though the evidence is not yet conclusive. Novo Nordisk, Ozempic Prescribing Information Potential Mechanisms of Interaction The exact ways GLP-1 receptor agonists affect gallbladder function are complex
Modern drug explorations Antihypertensive therapy Elevated BP after ICH onset is one of the most important modifiable predictors of poor outcome, strongly associated with hematoma expansion, perihematomal edema, and early neurological deterioration 45
, , ,
The pump may request a blood glucose check in certain situations when entering or maintaining SmartGuard mode, and you can enter blood glucose readings from your meter to help optimize sensor performance when needed
Daily GLP-1 is injected subcutaneously, meaning under skin, typically in the abdomen, thigh, or upper arm once daily